These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 17888541

  • 1. Conjugation of poorly absorptive drugs with mucoadhesive polymers for the improvement of oral absorption of drugs.
    Sakuma S, Matsumoto T, Yamashita S, Wang Y, Lu ZR.
    J Control Release; 2007 Nov 20; 123(3):195-202. PubMed ID: 17888541
    [Abstract] [Full Text] [Related]

  • 2. Alendronate-loaded microparticles for improvement of intestinal cellular absorption.
    Baek JS, Kwon HH, Hwang JS, Sung HC, Lee JM, Shin SC, Kim YR, Cho CW.
    J Drug Target; 2011 Jan 20; 19(1):37-48. PubMed ID: 20477555
    [Abstract] [Full Text] [Related]

  • 3. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
    Han HK, Shin HJ, Ha DH.
    Eur J Pharm Sci; 2012 Aug 15; 46(5):500-7. PubMed ID: 22522117
    [Abstract] [Full Text] [Related]

  • 4. Influence of cephalosporins on intestinal enzymatic activity.
    Jordán J, Idoate I, Urdaneta E, Larralde J.
    Rev Esp Fisiol; 1996 Mar 15; 52(1):31-6. PubMed ID: 8774083
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and study of alendronate derivatives as potential prodrugs of alendronate sodium for the treatment of low bone density and osteoporosis.
    Vachal P, Hale JJ, Lu Z, Streckfuss EC, Mills SG, MacCoss M, Yin DH, Algayer K, Manser K, Kesisoglou F, Ghosh S, Alani LL.
    J Med Chem; 2006 Jun 01; 49(11):3060-3. PubMed ID: 16722624
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis.
    Arns S, Gibe R, Moreau A, Monzur Morshed M, Young RN.
    Bioorg Med Chem; 2012 Mar 15; 20(6):2131-40. PubMed ID: 22341574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Absorption and safety of alendronate, a nitrogen-containing bisphosphonate, after intrapulmonary administration in rats.
    Katsumi H, Nakatani M, Sano J, Abe M, Kusamori K, Kurihara M, Shiota R, Takashima M, Fujita T, Sakane T, Hibi T, Yamamoto A.
    Int J Pharm; 2010 Nov 15; 400(1-2):124-30. PubMed ID: 20816731
    [Abstract] [Full Text] [Related]

  • 15. Stabilization of enzyme-susceptible glucoside bonds of phloridzin through conjugation with poly(gamma-glutamic acid).
    Sakuma S, Sagawa T, Masaoka Y, Kataoka M, Yamashita S, Shirasaka Y, Tamai I, Ikumi Y, Kida T, Akashi M.
    J Control Release; 2009 Jan 19; 133(2):125-31. PubMed ID: 18977257
    [Abstract] [Full Text] [Related]

  • 16. Multifunctional matrices for oral peptide delivery.
    Bernkop-Schnürch A, Walker G.
    Crit Rev Ther Drug Carrier Syst; 2001 Jan 19; 18(5):459-501. PubMed ID: 11763498
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
    Katsumi H, Liu S, Tanaka Y, Hitomi K, Hayashi R, Hirai Y, Kusamori K, Quan YS, Kamiyama F, Sakane T, Yamamoto A.
    J Pharm Sci; 2012 Sep 19; 101(9):3230-8. PubMed ID: 22467424
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.